The FDA decision will delay the drug’s possible launch by at least two years, according to company officials.
Read More »Yearly Archives: 2009
Atrial Fibrillation Increases Risk of Death in Diabetics
Led by Dr. Anushka Patel, of Royal Prince Alfred Hospital in Sydney, Australia, the authors of the study examined mortality and cardiovascular risks associated with atrial fibrillation in more than 11,000 patients with Type 2 diabetes. The researchers also sought to determine whether the effects of blood pressure lowering on …
Read More »Parents’ Skill at Carb Counting Linked to Diabetic Kids’ A1c Levels
Parental precision at carbohydrate counting is associated with improved glycemic control in children with Type 1 diabetes, according to a paper in the June issue of Diabetes Care.
Read More »Low Blood Sugar in Hospital Tied to Higher Death Risk
Being a diabetic and having just one episode of low blood sugar during a hospital stay was associated with a significantly increased risk of dying, both in the hospital and up to a year later, new research shows.
Read More »Higher Levels of a Certain Protein Associated with Lower Risk of Type 2 Diabetes
Persons with higher levels of adiponectin, a protein that is produced by fat cells and that has anti-inflammatory and insulin-sensitizing properties, have an associated lower risk of Type 2 diabetes, according to an analysis of previous studies.
Read More »ARB Slows Retinopathy but Not Nephropathy
Type 1 diabetes patients who start on renin-angiotensin blockers early may slow development of retinopathy by up to 70%, a clinical trial revealed. Michael Mauer, MD, of the University of Minnesota in Minneapolis, and colleagues reported that, neither an angiotensin-receptor blocker (ARB) nor an
Read More »New Hemoglobin Target Levels for Chronic Kidney Disease
In chronic kidney disease (CKD), the preferred hemoglobin target should be 9.0 to 12.0 g/dL, suggests the results of a systematic review and meta-analysis.
Read More »Lap-Band Surgery Reverses Metabolic Syndrome in Obese Teens
A new study of obese adolescents has shown that laparoscopic gastric banding surgery — the “Lap-Band” procedure — not only helps them achieve significant weight loss but can also improve and even reverse metabolic syndrome, reducing their risk for cardiovascular disease and diabetes.
Read More »How Long Can Bariatric Surgery Resolve Diabetes?
Weight-loss surgery allowed a majority of obese Type 2 diabetes patients to stop or reduce medical therapy, according to three studies. But how long is it effective?
Read More »Gastric Banding Less Effective than other Procedures
Patients who underwent laparoscopic adjustable gastric banding achieved less weight loss and less improvement in comorbid conditions than those who had gastric bypass or sleeve gastrectomy.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.